Related Experiment Video
Updated: Nov 4, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Risk Factors for COVID-19 in Patients with Hypertension
Xinxin Wang1, Haihua Zhang1, Huan Du1
1Department of Pulmonary and Critical Care Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, China.
Insights
Patients with hypertension and COVID-19 experienced more severe symptoms and higher mortality. Coronary heart disease, neutrophil count, and potassium levels were associated with COVID-19 severity in hypertensive patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pulmonology
Background:
- Hypertension is a common comorbidity in COVID-19 patients, linked to increased severity and mortality.
- Risk factors for severe COVID-19 outcomes in hypertensive individuals remain largely unknown.
Purpose of the Study:
- To identify risk factors associated with COVID-19 severity in patients with hypertension.
- To compare clinical characteristics and outcomes between COVID-19 patients with and without hypertension.
Main Methods:
- Retrospective analysis of 430 COVID-19 patients from Huoshenshan Hospital, China (February 3 - March 10, 2020).
- Propensity score matching (PSM) to compare 141 hypertensive patients with 141 non-hypertensive patients.
- Multivariate logistic regression to determine risk factors for COVID-19 severity in hypertensive patients.
Main Results:
- Hypertensive COVID-19 patients exhibited significantly higher severity rates (28.4% vs. 12.1%, p=0.001).
- Independent risk factors for hypertension in COVID-19 included coronary heart disease (OR: 5.281), elevated neutrophil count (OR: 1.471), and lower potassium levels (OR: 0.273).
- Higher pulmonary infection volume was observed in hypertensive patients (5.8 vs. 4.55, p=0.017) and was a significant risk factor for severe COVID-19 (OR: 1.084).
Conclusions:
- Coronary heart disease, neutrophil count, and potassium levels on admission are associated with COVID-19 outcomes in hypertensive patients.
- Increased pulmonary infection volume in hypertensive COVID-19 patients indicates a higher risk for disease severity.
Background:
Hypertension, as the most common comorbidity for patients with coronavirus disease 19 (COVID-19), has resulted in cases with more severe symptoms and higher mortality. The risk factors associated with COVID-19 in patients with hypertension are unknown.
Methods:
All the available and confirmed patients with COVID-19 from February 3 to March 10, 2020, were enrolled from Huoshenshan Hospital, Wuhan, China. The demographic characteristics, clinical manifestations, laboratory data, radiological assessments, and treatments on admission were extracted and compared. Univariate and multivariate logistic regression methods were used to explore risk factors associated with COVID-19 in patients with hypertension and the severity of the cohort.
Results:
A total of 430 available patients with COVID-19 were enrolled in the study, including 151 eligible patients with COVID-19 and hypertension. After PSM analysis, 141 patients without hypertension and 141 cases with hypertension were well matched. Compared with cases without hypertension, patients with hypertension were more severe (28.4% vs. 12.1%, p=0.001). In multivariate analysis, we found that neutrophil count (OR: 1.471; p=0.001), coronary heart disease (OR: 5.281; p=0.011), and the level of K+ (OR: 0.273; p < 0.001) were associated with patients with hypertension. In addition, the percentage of pulmonary infection volume was larger in cases with hypertension (4.55 vs. 5.8, p=0.017) and was a high risk factor for severe COVID-19 in patients with hypertension (OR: 1.084; p < 0.001).
Conclusion:
On admission, coronary heart disease, neutrophil count, and the level of K+ were associated with COVID-19 patients with hypertension. The percentage of the pulmonary infection volume was significantly larger in COVID-19 patients with hypertension and was a risk factor for COVID-19 severity of the cohort.
Related Concept Videos
Hypertension II: Pathophysiology
Factors affecting Blood pressure
Physiological Factors:
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Coronary Artery Disease I: Introduction

